Atlas Trials

A Challenge Study to Assess the Blood-stage Efficacy of Full-length SUM-101 Malaria Vaccine Candidate

Clinical trial NCT07124156 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07124156
Sponsor
European Vaccine Initiative
Status
NOT_YET_RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Malaria Fever
Start date
2026-03-20
Primary completion
2026-07-31
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.